Tridem

Active immunotherapies designed to engage the skin’s immune system.

Tridem Bioscience is a privately held biotech company based in Vienna, Austria, developing innovative active immunotherapies based on our proprietary WISIT (WIn the Skin Immune system Trick) technology.

We aim to realize this novel vaccine concept using Parkinson’s disease (PD) as our first indication. PD is the major representative of synucleopathies, a group of neurodegenerative diseases with high-unmet medical need.